Journal of Adolescent Health
Volume 47, Issue 3 , Pages 242-248.e6 , September 2010

Examining Future Adolescent Human Papillomavirus Vaccine Uptake, With and Without a School Mandate

  • Amanda F. Dempsey, M.D., Ph.D., M.P.H.

      Affiliations

    • Department of Pediatrics, Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, Michigan
    • Corresponding Author InformationAddress correspondence to: Amanda F. Dempsey, M.D., Ph.D., M.P.H., Department of Pediatrics, University of Michigan, 300 North Ingalls, Rm 6E08, Ann Arbor, MI 48109-5456.
    • ,
  • David Mendez, Ph.D.

      Affiliations

    • Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan

Received 30 July 2009 ,Accepted 8 December 2009.

References 

  1. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24
  2. Dunne EF, Datta SD, Markowitz LE. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer. 2008;113(suppl 10):2995–3003
  3. Guiliano A, Palefsky J; Male Quadrivalent HPV Vaccine Efficacy Trial Group. The efficacy of the quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV infection and HPV-related genital disease in young men. In: EUROGIN Conference; Nice, France. Abstract TC 2–11.
  4. U.S. Food and Drug Administration. FDA news release: FDA approves new vaccine for prevention of cervical cancer. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187048.htm. Accessed November 30, 2009.
  5. Kim JJ, Brisson M, Edmunds WJ, et al. Modeling cervical cancer prevention in developed countries. Vaccine. 2008;26(suppl 10):K76–K86
  6. Marra F, Cloutier K, Oteng B, et al. Effectiveness and cost effectiveness of human papillomavirus vaccine: A systematic review. Pharmacoeconomics. 2009;27:127–147
  7. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604–615
  8. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003;290:781–789
  9. Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004;10:1915–1923
  10. Sanders GD, Taira AV. Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis. 2003;9:37–48
  11. Goldie SJ, Kim JJ, Kobus K, et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine. 2007;25:6247–6270
  12. CDC. National vaccination coverage among adolescents aged 13–17 years—United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56:885–888
  13. McCauley MM, Stokley S, Stevenson J, et al. Adolescent vaccination: Coverage achieved by ages 13–15 years, and vaccinations received as recommended during ages 11–12 years, national health interview survey 1997–2003. J Adolesc Health. 2008;43:540–547
  14. Hoffner B. Vaccination against the human papillomavirus: The lessons we have not learned. Vaccine. 2008;27:2195–2198
  15. Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics. 2006;117:1486–1493
  16. Kahn JA, Rosenthal SL, Tissot AM, et al. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007;7:367–373
  17. Raley JC, Followwill KA, Zimet GD, et al. Gynecologists' attitudes regarding human papillomavirus vaccination: A survey of fellows of the American college of obstetricians and gynecologists. Infect Dis Obstet Gynecol. 2004;12:127–133
  18. Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: The attitudes of nurse practitioners. Sex Transm Dis. 2004;31:428–432
  19. Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18:391–398
  20. Broder KR, Cohn AC, Schwartz B, et al. Adolescent immunizations and other clinical preventive services: A needle and a hook?. Pediatrics. 2008;121(suppl 1):S25–S34
  21. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health. 2007;40:108–115
  22. Stretch R, Roberts SA, McCann R, et al. Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer. 2008;99:1908–1911
  23. Zimet GD, Liddon N, Rosenthal SL, et al. Psychosocial aspects of vaccine acceptability. Vaccine. 2006;24(suppl 3):S201–S209
  24. Orenstein WA, Hinman AR. The immunization system in the United States—The role of school immunization laws. Vaccine. 1999;17(suppl 3):S19–S24
  25. National Conference of State Legislatures. HPV vaccine legislation 2009-2010. Available at: http://www.ncsl.org/default.aspx?tabid=14381. Accessed April 28, 2008.
  26. Prochaska JO. Systems of Psychotherapy: A Transtheoretical Analysis. Pacific Grove, CA: Brooks-Cole; 1979;
  27. Becker M. The health belief model and personal health behavior. [entire issue] Health Educ Monogr. 1974;2:
  28. Fishbein M. Readings in Attitude Theory and Measurement. New York, NY: Wiley; 1967;
  29. U.S. Census Bureau, Population Division. Annual projections of the resident population by age, sex, race and Hispanic origin: Middle series data 1999–2100. Available at: http://www.census.gov/population/www/projections/natdet-D1A.html. Accessed July 10, 2007.
  30. Dempsey AF, Cohn L, Dalton V, et al. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine, in press.
  31. U.S. Census Bureau . Statistical Abstract of the United States: 2009. 128th edition. Washington DC: Department of Commerce, Bureau of Census; 2008;
  32. Dempsey AF, Abraham LM, Dalton V, et al. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531–538
  33. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13–17 years—United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:1100–1103
  34. CDC. National . state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:997–1001
  35. Centers for Disease Control and Prevention. Flu vaccination coverage trends. Available at: http://www.cdc.gov/flu/professionals/vaccination/pdf/vaccinetrend.pdf. Accessed July 13, 2009.
  36. Halpern-Felsher BL, Ozer EM, Millstein SG, et al. Preventive services in a health maintenance organization: How well do pediatricians screen and educate adolescent patients?. Arch Pediatr Adolesc Med. 2000;154:173–179
  37. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58:1405–1413
  38. Olshen E, Woods ER, Austin SB, et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37:248–251
  39. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43:239–245
  40. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ. 2008;336:1056–1058
  41. Donders GG, Gabrovska M, Bellen G, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet. 2008;277:291–298
  42. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Obstet Gynecol Surv. 2004;59:820–822
  43. Davis MM, Fant K. Coverage of vaccines in private health plans: What does the public prefer?. Health Aff (Millwood). 2005;24:770–779
  44. Sansom SL, Barker L, Corso PS, et al. Rotavirus vaccine and intussusception: How much risk will parents in the United States accept to obtain vaccine benefits?. Am J Epidemiol. 2001;154:1077–1085
  45. Newacheck PW, Park MJ, Brindis CD, et al. Trends in private and public health insurance for adolescents. JAMA. 2004;291:1231–1237
  46. Lee GM, Santoli JM, Hannan C, et al. Gaps in vaccine financing for underinsured children in the United States. JAMA. 2007;298:638–643
  47. Olshen E, Mahon BE, Wang S, Woods ER. The impact of state policies on vaccine coverage by age 13 in an insured population. J Adolesc Health. 2007;40:405–411
  48. Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine. 2006;24:3087–3094
  49. Nowalk MP, Lin CJ, Zimmerman RK, et al. Changes in parents' perceptions of infant influenza vaccination over two years. J Natl Med Assoc. 2007;99:636–641

PII: S1054-139X(09)00677-6

doi: 10.1016/j.jadohealth.2009.12.009

Journal of Adolescent Health
Volume 47, Issue 3 , Pages 242-248.e6 , September 2010

Article Tools

* Image Usage & Resolution